Details for New Drug Application (NDA): 087847
✉ Email this page to a colleague
NDA 087847 describes ATROPINE AND DEMEROL, which is a drug marketed by Abbvie and is included in three NDAs. Additional details are available on the ATROPINE AND DEMEROL profile page.
The generic ingredient in ATROPINE AND DEMEROL is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
The generic ingredient in ATROPINE AND DEMEROL is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
Summary for 087847
| Tradename: | ATROPINE AND DEMEROL |
| Applicant: | Abbvie |
| Ingredient: | atropine sulfate; meperidine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.4MG/ML;75MG/ML | ||||
| Approval Date: | Nov 26, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
